These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment. Karaba AH; Johnston TS; Beck E; Laeyendecker O; Cox AL; Klein SL; Sullivan DJ; mBio; 2023 Feb; 14(1):e0328722. PubMed ID: 36625657 [TBL] [Abstract][Full Text] [Related]
4. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM Front Immunol; 2022; 13():954093. PubMed ID: 36159791 [TBL] [Abstract][Full Text] [Related]
5. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers. Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480 [TBL] [Abstract][Full Text] [Related]
6. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples. Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567 [TBL] [Abstract][Full Text] [Related]
7. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals. Adami FL; de Castro MV; Almeida BDS; Daher IP; Yamamoto MM; Souza Santos K; Zatz M; Naslavsky MS; Rosa DS; Cunha-Neto E; de Oliveira VL; Kalil J; Boscardin SB Front Immunol; 2024; 15():1396603. PubMed ID: 38846944 [TBL] [Abstract][Full Text] [Related]
8. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889 [TBL] [Abstract][Full Text] [Related]
9. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Sampson AT; Heeney J; Cantoni D; Ferrari M; Sans MS; George C; Di Genova C; Mayora Neto M; Einhauser S; Asbach B; Wagner R; Baxendale H; Temperton N; Carnell G Viruses; 2021 Aug; 13(8):. PubMed ID: 34452443 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines. Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702 [TBL] [Abstract][Full Text] [Related]
11. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults. Tamminen K; Salminen M; Blazevic V Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402 [TBL] [Abstract][Full Text] [Related]
13. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination. Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022 [TBL] [Abstract][Full Text] [Related]
14. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013 [TBL] [Abstract][Full Text] [Related]
15. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43. Demers-Mathieu V; DaPra C; Mathijssen GB; Medo E J Perinatol; 2021 May; 41(5):952-960. PubMed ID: 33649442 [TBL] [Abstract][Full Text] [Related]
16. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography. Wang J; Li D; Zhou Q; Wiltse A; Zand MS Front Immunol; 2021; 12():696370. PubMed ID: 34386006 [TBL] [Abstract][Full Text] [Related]
17. Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers. Egwang TG; Owalla TJ; Okurut E; Apungia G; Fox A; De Carlo C; Powell RL Int J Infect Dis; 2021 Nov; 112():165-172. PubMed ID: 34547496 [TBL] [Abstract][Full Text] [Related]
18. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Chan KH; Cheng VC; Woo PC; Lau SK; Poon LL; Guan Y; Seto WH; Yuen KY; Peiris JS Clin Diagn Lab Immunol; 2005 Nov; 12(11):1317-21. PubMed ID: 16275947 [TBL] [Abstract][Full Text] [Related]
19. Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity. Stanley AM; Aksyuk AA; Wilkins D; Green JA; Lan D; Shoemaker K; Tieu HV; Sobieszczyk ME; Falsey AR; Kelly EJ Front Immunol; 2024; 15():1401728. PubMed ID: 38827749 [TBL] [Abstract][Full Text] [Related]
20. Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada. Tanunliong G; Liu AC; Kaweski S; Irvine M; Reyes RC; Purych D; Krajden M; Morshed M; Sekirov I; Gantt S; Skowronski DM; Jassem AN Front Immunol; 2022; 13():836449. PubMed ID: 35401521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]